Asthma clinical practice guidelines: The evolving role of leukotriene modifiers

Disease Management and Clinical Outcomes

Volumn 1, Issue 5, 1998, Pages 161-165

  Scardella, A T ^a  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE; MONTELUKAST; THEOPHYLLINE DERIVATIVE;

ARTICLE; ASTHMA; CLINICAL PRACTICE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE;

EID: 0032442561     PISSN: 10883371     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1088-3371(98)00021-7     Document Type: Article

References (31)

1. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Treatment of Asthma. National Institutes of Health pub no 91–3642. Bethesda, MD; 1991
2. National Heart, Lung and Blood Institute and World Health Organization. Global Initiative for Asthma. National Institutes of Health pub no 95–3659. Bethesda, MD; 1995
3. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Treatment of Asthma. National Institutes of Health pub no 97–4051. Bethesda, MD; 1997
4. P.K Jeffery A.J Wardlaw F.C Nelson J.V Collins A.B Kay Bronchial biopsies in asthma. An ultrastructural, qualitative study and correlation with hyperreactivity Am Rev Respir Dis 140 1989 1745 1753
5. R Djukanovic T.W Wilson K.M Britten S.J Wilson A.F Walls W.R Roche P.H Howarth S.T Holgate Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma Am Rev Respir Dis 145 1992 669 674
6. P.K Jeffery R.W Godfrey E Adelroth F Nelson A Rogers S.A Johansson Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study Am Rev Respir Dis 154 1992 890 899
7. P.J Barnes S Pederson Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992 Am Rev Respir Dis 148 1993 S1 S26
8. S.K Kamada S.J Szefler R.J Martin Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network Am J Respir Crit Care Med 153 1996 1739 1748
9. A Woolcock B Lundback N Ringdal L.A Jacques Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroid Am J Respir Crit Care Med 153 1996 1481 1488
10. D.M Lang M.S Sherman M Polansky Guidelines and realities of asthma management. The Philadelphia Story Arch Intern Med 157 1997 1193 1200
11. A.P Legorreta J Christian–Herman R.D O’Connor M.M Hasan R Evans K.M Leung Compliance with national asthma management guidelines and specialty care. A health maintenance organization experience Arch Int Med 158 1998 457 464
12. S.J Gaioni M Korenblat–Hanin E.B Fisher P Korenblat Treatment outcome in an outpatient asthma center retrospective questionnaire data Am J Man Care 2 1996 999 1008
13. C.L Emerman R.K Cydulka E Skobeloff Survey of asthma practice among emergency physicians Chest 109 1996 708 712
14. 4 on the airways in asthma N Engl J Med 308 1983 436 439
15. 4, and histamine in normal human subjects Thorax 39 1984 500 504
16. R.J Horwitz K.A McGill W.W Busse The role of leukotriene modifiers in the treatment of asthma Am J Respir Crit Care Med 157 1998 1363 1371
17. P.M O’Byrne E Israel J.M Drazen Antileukotrienes in the treatment of asthma Ann Intern Med 127 1997 472 480
18. E Israel J Cohn L Dube J.M Drazen Effect of treatment with Zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group JAMA 275 1996 931 936
19. 4 antagonist, in subjects with bronchial asthma. Accolate Asthma Trialists Group Am J Respir Crit Care Med 150 1995 618 623
20. T.F Reiss P Chervinsky R.J Dockhorn S Shingo B Seidenberg T.B Edwards Montelukast, a once-daily leukotriene antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group Arch Intern Med 158 1998 1213 1220
21. S.S Meltzer J.D Hasday J Cohn E.R Bleecker Inhibition of exercise-induced bronchospasm by zileuton a 5-lipooxygenase inhibitor Am J Respir Crit Care Med 153 1996 931 935
22. 4 receptor antagonist Am Rev Respir Dis 145 1992 746 749
23. J.A Leff W.W Busse D Pearlman Montelukast, a leukotriene antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction N Engl J Med 339 1998 147 152
24. E Israel A.R Fischer M.A Rosenberg C.M Lilly J.C Callery J Shapiro J Cohn P Rubin J.M Drazen The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin Am Rev Respir Dis 148 1993 1447 1451
25. S.E Dahlen K Malmstrom P Kuna Improvement of asthma in aspirin-intolerant patients Eur Respir J 10 1997 S419
26. B Knorr J Matz J.A Bernstien H Nguyen B.C Seidenberg T.F Reiss A Becker Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial JAMA 279 1998 1181 1186
27. E Garbe S Suissa J LeLorier Association of inhaled corticosteroid use with cataract extraction in elderly patients JAMA 280 1998 539 543
28. E Garbe J LeLorier J.F Boivin S Suissa Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma JAMA 277 1997 722 727
29. McCowan C, Neville RG, Thomas GE, et al. Effect of asthma and its treatment on growth: four year follow up of cohort children from general practices in Tayside, Scotland. BMJ 316:688–672, 1998
30. J.A Leff E Israel M.J Noonan Monelukast (MK-0476) allows tapering of inhaled corticosteroids (ICS) in asthmatic patients while maintaining clinical stability Am J Respir Crit Care Med 155 1997 A976
31. S Suissa R Dennis P Ernst O Sheehy S Wood–Dauphinee Effectiveness of the leukotriene receptor zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial Ann Intern Med 126 1997 177 183